Understanding Hepatocellular Carcinoma (HCC): Causes, Symptoms, Diagnosis, and Treatment

What is Hepatocellular Carcinoma (HCC)? Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for approximately 90% of all liver cancer diagnoses. It originates from the hepatocytes, the primary cells that make up the liver, constituting about 80% of its total cell population. HCC develops when these liver cells undergo DNA mutations, leading to uncontrolled growth and the formation of cancerous tumors. In the United States, the American Cancer Society estimated that around 41,210 individuals would be diagnosed with liver cancer in 2023, with a significant portion of these being HCC. Causes of Hepatocellular Carcinoma Over 90% of HCC cases are linked to chronic liver disease, a condition characterized by prolonged inflammation and damage to the liver, which can ultimately lead to cirrhosis. The primary risk factors for developing HCC include: Chronic Viral Hepatitis Long-term infections with the Hepatitis B or Hepatitis C virus are responsible for about 80% of HCC diagnoses worldwide. While Hepatitis C is more common in the United States and Europe, Hepatitis B is a more frequent cause in other global regions. Alcohol Consumption Excessive alcohol intake can severely damage the liver and is associated with approximately 30% of HCC diagnoses in the United States. Research indicates that consuming three or more alcoholic drinks daily can increase the risk of HCC by about 16%. Nonalcoholic Fatty Liver Disease (NAFLD) NAFLD occurs when excessive fat accumulates in the liver, often linked to conditions such as obesity and diabetes. In the United States, about 10% to 20% of HCC cases are attributed to NAFLD. Other Risk Factors Exposure to the fungal toxin aflatoxin B1 and certain rare health conditions can also contribute to HCC. These rare conditions include: Primary biliary cholangitis Hereditary hemochromatosis Alpha-1-antitrypsin deficiency Wilson’s disease Symptoms of Hepatocellular Carcinoma The symptoms of HCC can be subtle in the early stages and may overlap with those of underlying chronic liver disease. As the cancer progresses, individuals may experience: Unexplained weight loss Loss of appetite Upper abdominal pain, particularly on the right side, or pain radiating to the right shoulder blade Nausea and vomiting General weakness and fatigue Abdominal swelling (ascites) Jaundice, characterized by yellowing of the skin and the whites of the eyes Itchy skin It's important to note that many of these symptoms can be caused by other conditions, making early and accurate diagnosis crucial. Diagnosis of Hepatocellular Carcinoma Diagnosing HCC typically involves a comprehensive approach: Medical History and Physical Examination Your doctor will begin by reviewing your medical history, paying close attention to risk factors like chronic liver disease, viral hepatitis, or heavy alcohol use. A physical examination may reveal signs of liver dysfunction. Blood Tests Several blood tests are ordered to assess liver function and screen for specific markers: Liver function tests (LFTs) Alpha-fetoprotein (AFP) levels: Elevated AFP can be an indicator of HCC, though it's not always present. Tests for Hepatitis B and C infections Imaging Tests If HCC is suspected, imaging techniques are used to visualize the liver and detect tumors: Ultrasound: A non-invasive test using sound waves to create images of the liver. Computed Tomography (CT) scan: Provides detailed cross-sectional images of the liver. Magnetic Resonance Imaging (MRI): Uses magnetic fields and radio waves to generate highly detailed images, often preferred for its ability to detect small tumors. In most cases, the characteristic appearance of HCC on imaging tests is sufficient for diagnosis, and a liver biopsy may not be necessary. However, a biopsy might be performed if the imaging results are atypical. Staging Once diagnosed, HCC is staged to determine the extent of the cancer. This involves assessing: The size and number of tumors Whether the cancer has spread to nearby lymph nodes Whether the cancer has metastasized to distant organs like the bones or lungs Liver function is also a critical component of staging, often evaluated using systems like the Barcelona Clinic Liver Cancer (BCLC) system, which considers both cancer extent and liver health. Treatment for Hepatocellular Carcinoma The treatment plan for HCC is highly individualized and depends on several factors, including the stage of the cancer, the patient's overall health, and the degree of liver function. Treatment options aim to remove or destroy the cancer and may include: Surgery Liver Transplant: For eligible patients with early-stage HCC and severe liver disease, a liver transplant can be a curative option. It involves replacing the diseased liver with a healthy donor liver. Resection: Surgical removal of the cancerous part of the liver. This is typically an option for patients with small tumors confined to a specific area of the liver and good liver function. Loco-regional Therapies These treatments are applied directly to the tumor within the liver: Chemoembolization (TACE): A procedure where chemotherapy drugs are delivered directly to the tumor via its blood supply, followed by blocking the blood vessel to starve the tumor. Radiofrequency Ablation (RFA) or Microwave Ablation (MWA): Uses heat generated by radio waves or microwaves to destroy cancer cells. External Beam Radiation Therapy: High-energy rays are used to kill cancer cells. Systemic Therapies These treatments are administered throughout the body: Targeted Therapy: Drugs that specifically target cancer cells, often by blocking pathways that promote tumor growth. Immunotherapy: Treatments that harness the body's immune system to fight cancer. Chemotherapy: While less effective for HCC on its own, it may be used in combination with other treatments or for advanced disease. Prevention of Hepatocellular Carcinoma

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.